FAC. FARMÀCIA
Centre
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (37)
2023
-
Metabolomic profiles of chronic distress are associated with cardiovascular disease risk and inflammation-related risk factors
Brain, Behavior, and Immunity, Vol. 114, pp. 262-274
-
Universal research index: An inclusive metric to quantify scientific research output
Journal of Academic Librarianship, Vol. 49, Núm. 3
2022
-
Emerging Standards and the Hybrid Model for Organizing Scientific Events during and after the COVID-19 Pandemic
Disaster Medicine and Public Health Preparedness, Vol. 16, Núm. 3, pp. 1172-1177
-
Genetic Predictors of Change in Waist Circumference and Waist-to-Hip Ratio With Lifestyle Intervention: The Trans-NIH Consortium for Genetics of Weight Loss Response to Lifestyle Intervention
Diabetes, Vol. 71, Núm. 4, pp. 669-676
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes
American Journal of Clinical Nutrition, Vol. 111, Núm. 4, pp. 835-844
-
Mendelian randomization analysis does not support causal associations of birth weight with hypertension risk and blood pressure in adulthood
European Journal of Epidemiology, Vol. 35, Núm. 7, pp. 685-697
2019
-
Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study
JAMA network open, Vol. 2, Núm. 9, pp. e1910915
-
High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 10, pp. 1040-1049
-
Plasma acylcarnitines and risk of type 2 diabetes in a mediterranean population at high cardiovascular risk
Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 5, pp. 1508-1519
-
Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study
Nutrients, Vol. 11, Núm. 5
2018
-
Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial: A case–cohort study
Clinical Chemistry, Vol. 64, Núm. 8, pp. 1211-1220
-
Lipid metabolic networks, Mediterranean diet and cardiovascular disease in the PREDIMED trial
International Journal of Epidemiology, Vol. 47, Núm. 6, pp. 1830-1845
-
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Journal of Extracellular Vesicles, Vol. 7, Núm. 1
-
Plasma lipidomic profiling and risk of type 2 diabetes in the PREDIMED trial
Diabetes Care, Vol. 41, Núm. 12, pp. 2617-2624
2017
-
Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade
Journal of Thoracic Oncology, Vol. 12, Núm. 8, pp. 1268-1279
-
Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet
American Journal of Clinical Nutrition, Vol. 106, Núm. 4, pp. 973-983
-
Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevencí on con Dieta Mediterŕanea (PREDIMED) study
American Journal of Clinical Nutrition, Vol. 105, Núm. 3, pp. 723-735